The Mineralocorticoid Antagonist Activity of an 11β, 18-Oxidopregnane*
- 1 May 1979
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 104 (5) , 1352-1356
- https://doi.org/10.1210/endo-104-5-1352
Abstract
Removal of the 18-hydroxy group of the hemiacetal form of aldosterone transforms its activity from that of pure agonist to predominant antagonist. The 18-deoxy derivative possesses one third of the binding affinity of aldosterone for the cytoplasmic mineralocorticoid receptor of rat kidney and exhibits an approximate 2:1 antagonist to agonist ratio in both toad bladder and adrenalectomized rat bioassay systems. The promising properties of the 11β,l8-oxidopregnane tested included very low androgen receptor affinity and approximately equal effectiveness in vitro and in vivo in displacing aldosterone from mineralocorticoid-binding sites in the rat.Keywords
This publication has 1 reference indexed in Scilit:
- Pathophysiology of Spironolactone-Induced GynecomastiaAnnals of Internal Medicine, 1977